Advertisement
Review Article| Volume 32, ISSUE 3, P705-726, September 2005

Download started.

Ok

Diagnosis and Management of Toxoplasmosis

  • Jose G. Montoya
    Correspondence
    Corresponding author. Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Grant S-169, Stanford, CA 94305-5107
    Affiliations
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Grant S-169, Stanford, CA 94305-5107, USA

    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301, USA
    Search for articles by this author
  • Fernando Rosso
    Affiliations
    Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Grant S-169, Stanford, CA 94305-5107, USA

    Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301, USA

    Fundación Clínica Valle del Lili, Cali, Colombia
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Remington J.S.
        • McLeod R.
        • Desmonts G.
        Toxoplasmosis.
        in: Remington J.S. Klein J.O. Infectious diseases of the fetus and newborn infant. 5th edition. W. B. Saunders Company, Philadelphia2001: 205-346
        • Desmonts G.
        • Couvreur J.
        Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy. Pathophysiology of congenital disease [with letter].
        in: Thalhammer O. Pollak A. Baumgarten K. Perinatal medicine, 6th European Congress, Vienna. Georg Thieme Publishers, Stuttgart (Germany)1979: 51-60
        • Koppe J.G.
        • Loewer-Sieger D.H.
        • De Roever-Bonnet H.
        Results of 20-year follow-up of congenital toxoplasmosis.
        Am J Ophthalmol. 1986; 101: 248-249
        • Wilson C.B.
        • Remington J.S.
        • Stagno S.
        • et al.
        Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.
        Pediatrics. 1980; 66: 767-774
        • Bowie W.R.
        • King A.S.
        • Werker D.H.
        • et al.
        Outbreak of toxoplasmosis associated with municipal drinking water.
        Lancet. 1997; 350: 173-177
        • Miller M.A.
        • Grigg M.E.
        • Kreuder C.
        • et al.
        An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a cause of mortality.
        Int J Parasitol. 2004; 34: 275-284
        • Dubey J.P.
        • Graham D.H.
        • da Silva D.S.
        • et al.
        Toxoplasma gondii isolates of free-ranging chickens from Rio de Janeiro, Brazil: mouse mortality, genotype, and oocyst shedding by cats.
        J Parasitol. 2003; 89: 851-853
        • Bahia-Oliveira L.M.
        • Jones J.L.
        • Azevedo-Silva J.
        • et al.
        Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.
        Emerg Infect Dis. 2003; 9: 55-62
        • Miller M.A.
        • Gardner I.A.
        • Kreuder C.
        • et al.
        Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis).
        Int J Parasitol. 2002; 32: 997-1006
        • Jones J.L.
        • Kruszon-Moran D.
        • Wilson M.
        Toxoplasma gondii infection in the United States, 1999–2000.
        Emerg Infect Dis. 2003; 9: 1371-1374
        • Lopez A.
        • Dietz V.J.
        • Wilson M.
        • et al.
        Preventing congenital toxoplasmosis.
        MMWR Recomm Rep. 2000; 49: 59-68
        • Gilbert R.E.
        • Gras L.
        • Wallon M.
        • et al.
        Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
        Int J Epidemiol. 2001; 30: 1303-1308
        • Gilbert R.
        • Gras L.
        European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
        BJOG. 2003; 110: 112-120
        • Montoya J.G.
        • Kovacs J.A.
        • Remington J.S.
        Toxoplasma gondii.
        in: Mandell G.L. Bennett J.E. Dolin R. Principles and practice of infectious diseases. vol. 2. Elsevier Churchill Livingstone, Philadelphia2005: 3170-3198
        • Montoya J.G.
        • Remington J.S.
        Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis.
        Clin Infect Dis. 1996; 23: 277-282
        • Montoya J.G.
        • Remington J.S.
        Studies on the serodiagnosis of toxoplasmic lymphadenitis.
        Clin Infect Dis. 1995; 20: 781-790
        • Montoya J.G.
        • Liesenfeld O.
        • Kinney S.
        • et al.
        VIDAS test for avidity of toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.
        J Clin Microbiol. 2002; 40: 2504-2508
        • Liesenfeld O.
        • Press C.
        • Montoya J.G.
        • et al.
        False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.
        J Clin Microbiol. 1997; 35: 174-178
        • Wilson M.
        • Remington J.S.
        • Clavet C.
        • et al.
        Evaluation of six commercial kits for detection of human immunoglobulin M antibiodies to Toxoplasma gondii.
        J Clin Microbiol. 1997; 35: 3112-3115
        • US Public Health Service
        • Department of Health and Human Services
        • and Food and Drug Administration
        FDA public health advisory: limitations of toxoplasma IgM commerical test kits. Department of Health and Human Services, Food and Drug Administration, Rockville (MD)1997
        • Liesenfeld O.
        • Montoya J.G.
        • Tathineni N.J.
        • et al.
        Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive toxoplasma immunoglobulin M antibody titers.
        Am J Obstet Gynecol. 2001; 184: 140-145
        • Montoya J.G.
        • Jordan R.
        • Lingamneni S.
        • et al.
        Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life.
        Clin Infect Dis. 1997; 24: 676-683
        • Hedman K.
        • Lappalainen M.
        • Seppala I.
        • et al.
        Recent primary toxoplasma infection indicated by a low avidity of specific IgG.
        J Infect Dis. 1989; 159: 736-739
        • Lappalainen M.
        • Koskela P.
        • Koskiniemi M.
        • et al.
        Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG.
        J Infect Dis. 1993; 167: 691-697
        • Cozon G.J.
        • Ferrandiz J.
        • Nebhi H.
        • et al.
        Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women.
        Eur J Clin Microbiol Infect Dis. 1998; 17: 32-36
        • Jenum P.A.
        • Stray-Pedersen B.
        • Gundersen A.-G.
        Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G activity.
        J Clin Microbiol. 1997; 35: 1972-1977
        • Gutiérrez J.
        • Rodríguez M.
        • Piédrola G.
        • et al.
        Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis.
        Clin Microbiol Infect. 1997; 3: 658-662
        • Holliman R.
        • Raymond R.
        • Renton N.
        • et al.
        The diagnosis of toxoplasmosis using IgG avidity.
        Epidemiol Infect. 1994; 112: 399-408
        • Liesenfeld O.
        • Montoya J.G.
        • Kinney S.
        • et al.
        Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory.
        J Infect Dis. 2001; 183: 1248-1253
        • Montoya J.G.
        • Huffman H.B.
        • Remington J.S.
        Evaluation of the immunoglobulin g avidity test for diagnosis of toxoplasmic lymphadenopathy.
        J Clin Microbiol. 2004; 42: 4627-4631
        • Remington J.S.
        • Thulliez P.
        • Montoya J.G.
        Recent developments for diagnosis of toxoplasmosis.
        J Clin Microbiol. 2004; 42: 941-945
        • Romand S.
        • Wallon M.
        • Franck J.
        • et al.
        Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis.
        Obstet Gynecol. 2001; 97: 296-300
        • Daffos F.
        • Forestier F.
        • Capella-Pavlovsky M.
        • et al.
        Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
        N Engl J Med. 1988; 318: 271-275
        • Schoondermark-Van de Ven E.
        • Galama J.
        • Camps W.
        • et al.
        Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus.
        Antimicrob Agents Chemother. 1994; 38: 1922-1929
        • Gilbert R.
        • Dunn D.
        • Wallon M.
        • et al.
        Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol.
        Epidemiol Infect. 2001; 127: 113-120
        • Thulliez P.
        Commentary: efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out.
        Int J Epidemiol. 2001; 30: 1315-1316
        • Mitchell C.D.
        • Erlich S.S.
        • Mastrucci M.T.
        • et al.
        Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
        Pediatr Infect Dis J. 1990; 9: 512-518
        • Stepick-Biek P.
        • Thulliez P.
        • Araujo F.G.
        • et al.
        IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.
        J Infect Dis. 1990; 162: 270-273
        • McAuley J.
        • Boyer K.M.
        • Patel D.
        • et al.
        Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
        Clin Inf Dis. 1994; 18: 38-72
        • McGee T.
        • Wolters C.
        • Stein L.
        • et al.
        Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis.
        Otolarygol Head Neck Surg. 1992; 106: 75-80
        • Mets M.B.
        • Holfels E.
        • Boyer K.M.
        • et al.
        Eye manifestations of congenital toxoplasmosis.
        Am J Opthalmol. 1996; 122: 309-324
        • Roizen N.
        • Swisher C.N.
        • Stein M.A.
        • et al.
        Neurologic and developmental outcome in treated congental toxoplasmosis.
        Pediatrics. 1995; 95: 11-20
        • Wong S.
        • Remington J.S.
        Toxoplasmosis in pregnancy.
        Clin Infect Dis. 1994; 18: 853-862
        • Foulon W.
        • Naessens A.
        • Lauwers S.
        • et al.
        Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.
        Obstet Gynecol. 1988; 72: 363-366
        • Eaton R.B.
        • Petersen E.
        • Seppanen H.
        • et al.
        Multicenter evaluation of a flurometric enzyme immunocapture assay to detect toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns.
        J Clin Microbiol. 1996; 34: 3147-3150
        • Petersen E.
        • Eaton R.B.
        Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples.
        Acta Paediatr. 1999; 88: 36-39